drugset / Trial / NCT03619330

Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.

NCT03619330

Phase 4 Completed 30 enrolled University Medical Centre Ljubljana
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study was to compare the effects of liraglutide and testosterone replacement therapy on features of hypogonadism and weight loss in obese men with persistent features of hypogonadism after unsuccessful lifestyle measures.

Timeline

Start
2014-12
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Liraglutide Peptide 3 mg Subcutaneous
Comparator Testosterone Small molecule 50 mg Topical